Skip to content
The Quiet Ledger
hr 3884 · 118th Congress · House

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

Sign in to watch / set alerts
TQL analysis
Not yet gradedThis bill has no published Quiet Ledger grade yet.
Legislative structure
Cosponsors
3 current · 3 total
Actions
12
Roll calls
0
Criterion breakdown8 criteria · max 90
No grade to break down.
Actions (12)
DateTimeAction
2023-06-07Referred to the House Committee on Energy and Commerce.
2023-06-07Introduced in House
2023-06-07Introduced in House
2023-08-25Placed on the Union Calendar, Calendar No. 132.
2023-08-25Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
2023-08-25Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
2024-09-2315:13:18Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
2024-09-2315:13:33Considered under suspension of the rules. (consideration: CR H5578-5580)
2024-09-2315:13:36DEBATE - The House proceeded with forty minutes of debate on H.R. 3884.
2024-09-2315:28:12On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
2024-09-2315:28:12Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
2024-09-2315:28:17Motion to reconsider laid on the table Agreed to without objection.

The Quiet Ledger grades legislation on its content. A bill grade is analysis of the bill — not a grade of its sponsor or of any member who voted on it.